Replies to post #85324 on Anavex Life Sciences Corp (AVXL)

[McMagyar]

I disagree with part of your conclusion but agree with other parts,,
The company basically does say
That trial participants have changed their medication by dropping the Anavex Monotherapy designation..
There obviously is a reason Dual Therapy is no longer quantified and IMO it is because so many patients are no longer on Aricept.
But I agree that the change to Monotherapy has happened over a longer period of time .. I would argue probably at 6 months .. many patients stopped taking Aricept..as IS and WAS their RIGHT! They didn't sign up to be Placebo Group they signed up for ADAPTIVE trial.. and they adapted!
Brilliant. It just seems the astutes do not wish to adapt. I hope they get trumped!